[1] Lohmann V. Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development. Med Microbiol Immunol,2019,208: 3-24.
[2] Hamdane N, Jühling F, Crouchet E, et al. HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response. Gastroenterology,2019,156:2313-2329.e7.
[3] Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol Cell,2013,49: 825-837.
[4] Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell,2012,150: 12-27. |
